GLOBAL DIABETES DRUGS MARKET FORECAST 2019-2027

1
GLOBAL DIABETES DRUGS MARKET

• FORECAST 2019-2027

1
2
MARKET OVERVIEW
GLOBAL DIABETES DRUGS MARKET FORECAST 2019-2027

• The important driver for the growth in this
  market is the increase in the prevalence of
  diabetes which is because of the increasing
  obesity among people caused by unhealthy diets
  and sedentary lifestyles.
• The diabetes drugs market segments include
  diabetes type and product class.
• Diabetes drugs manufacturers offer products for
  use by both the types (type 1 and type 2) of
  diabetic patients.
• Growing elderly population is also influencing
  the market growth in a big way as the life
  expectancy rate is rising and the birth rate is
  declining at the same time.

3
INTRODUCTION
KEY FINDINGS

• The growth in the global diabetes drugs market is
  mainly driven by increased diabetic population
  and obesity rates in recent years.
• The North American market holds the largest share
  of the global market.
• The global diabetes drugs market is expected to
  grow at a CAGR of 6.50 during the forecast
  period of 2019-2027.

• Global Diabetes Drugs market by Diabetes type, by
  Product class, by Non-Insulin by geography.

4
Infographic
5
REQUEST FREE SAMPLE
To know more about the latest trends and
innovation in the Global Diabetes Drugs market
Request free sample
5
6
NORTH AMERICA DIABETES DRUGS MARKET

• The expected CAGR of the North American diabetes
  drugs market over the forecast period of
  2019-2027 is 4.98.
• The region has the worlds most established
  market for diabetes drugs and holds more than
  half of the total market share.
• The US market holds the maximum share in the sale
  and distribution of diabetes drugs.

Request free sample
6
7
EUROPE DIABETES DRUGS MARKET

• The CAGR for the European market of diabetes
  drugs is expected to be 5.09 for the forecast
  period of 2019-2027.
• The increase in life expectancy contributes to
  the increase in the number of diseases prevailing
  in the region, especially diabetes. Implications
  caused by diabetes such as CVDs, kidney failure,
  foot ulcers and damage to the eyes have made
  people in Europe more conscious about diabetes
  management.

Request free sample
7
8
ASIA PACIFIC DIABETES DRUGS MARKET

• The CAGR for the Asia Pacific diabetes drugs
  market is expected to be 10.82 for the forecast
  period of 2019-2027.
• Economic development and rise in healthcare
  spending are expected to increase the demand for
  diabetes drugs further.
• Despite a large number of people with diabetes in
  the region, awareness is still low, and therefore
  the situation needs to be addressed.

Request free sample
8
9
COMPETITIVE INSIGHTS

• Leading brands in the global market of diabetes
  drugs are Eli Lilly And Company, AstraZeneca
  Plc., B.Braun Melsungen Ag, Novo Nordisk A/S,
  Sanofi, Diavacs Inc., Xoma Corp., Albireo Pharma
  Inc., Macrogenics Inc., Astellas Pharma,
  Glaxosmithkline, Merck, Pfizer and Xeris
  Pharmaceuticals.

9
10
(No Transcript)
11
CONTACT US

• 1 857-302-4704

• sales_at_inkwoodresearch.com

• https//www.inkwoodresearch.com/

11
12

• THANK YOU

Follow us on
12